Evidence map›Paper›PMID 35292630›Full record

ArticleNature communications2022

Gut microbiota and fermentation-derived branched chain hydroxy acids mediate health benefits of yogurt consumption in obese mice.

Noëmie Daniel, Renato Tadeu Nachbar, Thi Thu Trang Tran, Adia Ouellette, Thibault Vincent Varin, Aurélie Cotillard, Laurent Quinquis, Andréanne Gagné, Philippe St-Pierre, Jocelyn Trottier and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 86 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Isolation and Mechanistic Characterization ofFoods (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 4 countries.

Noëmie Daniel *Quebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Renato Tadeu Nachbar *Quebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Thi Thu Trang TranDanone Nutricia Research, Palaiseau, France.
Adia OuelletteQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Thibault Vincent VarinQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Aurélie CotillardDanone Nutricia Research, Palaiseau, France.
Laurent QuinquisDanone Nutricia Research, Palaiseau, France.
Andréanne GagnéQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.ORCID http://orcid.org/0000-0002-3833-4159
Philippe St-PierreQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Jocelyn TrottierLaboratory of molecular pharmacology, CHU of Québec Research Center and Faculty of Pharmacy, Québec, Canada.
Bruno MarcotteQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Marion PoirelIT&M Innovation on behalf of Danone Nutricia Research, Neuilly-sur-Seine, France.
Mathilde SaccareauSoladis on behalf on Danone Nutricia Research, Paris, France.
Marie-Julie DuboisQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Philippe JoubertQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada.
Olivier BarbierLaboratory of molecular pharmacology, CHU of Québec Research Center and Faculty of Pharmacy, Québec, Canada.
Hana KoutnikovaDanone Nutricia Research, Palaiseau, France. hana.koutnikova-rousselin@danone.com.ORCID http://orcid.org/0000-0001-7763-8983
André MaretteQuebec Heart and Lung Institute (IUCPQ), Laval University, Québec, Canada. andre.marette@criucpq.ulaval.ca.ORCID http://orcid.org/0000-0003-3950-5973
Institut universitaire de cardiologie et de pneumologie de Québec · CADanone (France) · FRLung Institute · US

Funding

CIHR FDN-143247
6 · The paper itself

Abstract

Meta-analyses suggest that yogurt consumption reduces type 2 diabetes incidence in humans, but the molecular basis of these observations remains unknown. Here we show that dietary yogurt intake preserves whole-body glucose homeostasis and prevents hepatic insulin resistance and liver steatosis in a dietary mouse model of obesity-linked type 2 diabetes. Fecal microbiota transplantation studies reveal that these effects are partly linked to the gut microbiota. We further show that yogurt intake impacts the hepatic metabolome, notably maintaining the levels of branched chain hydroxy acids (BCHA) which correlate with improved metabolic parameters. These metabolites are generated upon milk fermentation and concentrated in yogurt. Remarkably, diet-induced obesity reduces plasma and tissue BCHA levels, and this is partly prevented by dietary yogurt intake. We further show that BCHA improve insulin action on glucose metabolism in liver and muscle cells, identifying BCHA as cell-autonomous metabolic regulators and potential mediators of yogurt's health effects.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeAnimalsFermentationHydroxy AcidsMiceMice, ObeseYogurtHydroxy Acids

Identifiers

PMID35292630
PMCPMC8924213
OpenAlexW4220805131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.